Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/68CC8CC078DF8A7F9DE94613CB439AF3DD8A211D35BDE6EE1FFFD6AE06E9640B1221DF58A25DE34F2AE079BCB84D0BA5http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/68CC8CC078DF8A7F9DE94613CB439AF3DD8A211D35BDE6EE1FFFD6AE06E9640B1221DF58A25DE34F2AE079BCB84D0BA5http://www.w3.org/2000/01/rdf-schema#comment"Study observed a significant decrease of miRNA-101 intracellular levels in everolimus-resistant clear cell renal cell carcinoma cell line (786-OR) and significant increase of HIF-2alpha in 786-OR. The circulating levels of miRNA-101 may be a potential biomarker of anti-mTOR therapy response and resistance prediction. Moreover the resistance to mTOR inhibitors seems to be related with the overexpression of HIF-2alpha."xsd:string
http://purl.uniprot.org/uniprot/#_5918F0CF42C140C1224AA4703A58C51B230C934C0ADFDE9803FD876B53F1F73B12A08CF82E99C1318AC72926F5621790http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/68CC8CC078DF8A7F9DE94613CB439AF3DD8A211D35BDE6EE1FFFD6AE06E9640B1221DF58A25DE34F2AE079BCB84D0BA5
http://purl.uniprot.org/uniprot/Q99814http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/68CC8CC078DF8A7F9DE94613CB439AF3DD8A211D35BDE6EE1FFFD6AE06E9640B1221DF58A25DE34F2AE079BCB84D0BA5
http://purl.uniprot.org/uniprot/#_Q99814-mappedCitation-31267758http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/68CC8CC078DF8A7F9DE94613CB439AF3DD8A211D35BDE6EE1FFFD6AE06E9640B1221DF58A25DE34F2AE079BCB84D0BA5